EIN 51-0181215

Israel Cancer Research Fund

IRS 501(c) type
501(c)(3)
Num. employees
17
Year formed
1975
Most recent tax filings
2022-12-01
NTEE code, primary
Description
The Israel Cancer Research Fund supports Cancer Research in Israel with the mission of benefiting both Israel and all mankind. It provides funding for Israeli scientists, making it the largest non-profit in North America dedicated to this cause, having given over $87.5 million over 40 years. ICRF also supports the development of the next generation of Israeli cancer scientists by funding postdoctoral fellowships, research career development awards, and doctoral fellowships. Its headquarters is located in New York, NY.
Total revenues
$5,734,601
2022
Total expenses
$6,217,607
2022
Total assets
$16,331,164
2022
Num. employees
17
2022

Program areas at Israel Cancer Research Fund

Provide Cancer Research funding for israeli scientists. Icrf is the largest non-profit in north america dedicated to supporting Cancer Research in Israel. Over the last 40 years, icrf has provided more than $87.5 million to support Cancer Research in Israel, funding over 2,700 Research projects at all of the major israeli Research institutions. Typically, 60-80 grants are funded annually, based on an evaluation and prioritization by independent review panels consisting of 40-50 leading Cancer scientists from north american biomedical Research centers. Icrf grant categories are tailored to support Cancer researchers at all of the various stages of their careers, and we are proud to have helped support many of today's most outstanding scientists at the earliest stages in their careers. Icrf seeks to capitalize on the significantly lower costs of conducting Cancer Research in Israel. All awards go directly to the designated researcher without any reduction for overhead. In 2021, we awarded 49 Research grants valued at nearly $2.795m.
Support collaborative Cancer Research conducted by israeli scientists in association with north american Cancer scientists. Cancer science oftentimes requires multi-disciplinary approaches, engagement with highly specialized areas of science, and expensive equipment that is not easily accessed. Collaborations between scientists in Israel and north america can address these challenges, foster unexpected synergies, and enhance both intellectual curiosity and innovation. Icrf promotes collaboration by supporting grants that Fund promising Cancer Research projects being conducted on a collaborative basis between investigators in Israel and an american or canadian Research institution.
Support the development of the next generation of israeli Cancer scientists. Icrf is committed to facilitating the development of future Cancer scientists in Israel. Towards this end icrf funds three types of grants: postdoctoral fellowship awards, Research career development awards, and clinical Research career development awards. Fellowships support mds and phds who have just completed their postgraduate training. These awards can be used to support salaries or Research costs, while these individuals apprentice in the laboratories of senior investigators. Career development awards are to enhance the Research capabilities of young israeli scientists in the formative phase of their careers. Candidates must have demonstrated outstanding potential for contributions to Cancer Research and must exhibit great potential to become independent investigators Research. Supporting these newly launched scientists, enhances their opportunities in Israel and allows them to optimize their work without emigrating to other advanced countries.

Grants made by Israel Cancer Research Fund

GranteeGrant descriptionAmount
Partners Healthcare System / Brigham & Womens Hospital IncCancer Research$30,000

Who funds Israel Cancer Research Fund

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Vanguard Charitable Endowment ProgramFor Recipient's Exempt Purpose$668,800
Jewish Communal FundIn Furtherance of Grantee's Tax-Exempt Purpose$407,125
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$398,281
...and 113 more grants received totalling $3,890,410

Personnel at Israel Cancer Research Fund

NameTitleCompensation
Stu Guttman MontrealChief Executive Officer
Caitlin ShmidheiserChief Development Officer$181,227
Alan HermanExecutive Director International Headquarters$209,357
Allyson MarksExecutive Director
Gayle PeckDirector of Communications International Headquarters
...and 21 more key personnel

Financials for Israel Cancer Research Fund

RevenuesFYE 12/2022
Total grants, contributions, etc.$5,860,881
Program services$0
Investment income and dividends$182,826
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$-5,987
Net income from fundraising events$-303,119
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$5,734,601

Form 990s for Israel Cancer Research Fund

Fiscal year endingDate received by IRSFormPDF link
2022-122023-09-28990View PDF
2021-122022-11-09990View PDF
2020-122021-08-03990View PDF
2019-122021-02-22990View PDF
2018-122019-12-06990View PDF
...and 9 more Form 990s
Data update history
September 13, 2024
Updated personnel
Identified 1 new personnel
August 10, 2024
Received grants
Identified 33 new grant, including a grant for $231,370 from Jewish Federation of Metropolitan Chicago (JUF)
May 18, 2024
Received grants
Identified 1 new grant, including a grant for $407,125 from Jewish Communal Fund
January 3, 2024
Received grants
Identified 33 new grant, including a grant for $200,000 from The Diane and Guilford Glazer Foundation
December 19, 2023
Updated personnel
Identified 1 new personnel
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsHeadquarter / parent organizationsCharities
Issues
HealthDiseases and disordersCancer
Characteristics
Conducts researchFundraising eventsOperates internationallyNational levelEndowed supportGala fundraisersTax deductible donationsAccepts online donations
General information
Address
52 Vanderbilt Ave 1410
New York, NY 10017
Metro area
New York-Newark-Jersey City, NY-NJ-PA
County
New York County, NY
Website URL
icrfonline.org/international-bot/ 
Phone
(212) 969-9800
Facebook page
ICRFNY 
Twitter profile
@icrfny 
IRS details
EIN
51-0181215
Fiscal year end
December
Taxreturn type
Form 990
Year formed
1975
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H30: Cancer Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
California AB-488 details
AB 488 status
May Operate or Solicit for Charitable Purposes
Charity Registration status
Current - Awaiting Reporting
FTB status revoked
Revoked
AG Registration Number
062756
FTB Entity ID
1246335
AB 488 data last updated ("as-of") date
2024-10-16
Free account sign-up

Want updates when Israel Cancer Research Fund has new information, or want to find more organizations like Israel Cancer Research Fund?

Create free Cause IQ account